Hexagon Nutrition intimated a board meeting on 14 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes from 01 Oct until 48 hours after results declaration.
Hexagon Nutrition shareholders approved Arun Purushottam Kelkar as Executive Director and Chairman, effective October 28, 2026. He has been with the company since its incorporation.
Hexagon Nutrition held its EGM on 28 October 2026 and summarised proceedings. Resolutions covered appointment of Arun Kelkar as Executive Director and Chairman, plus related remuneration approvals.
Hexagon Nutrition dispatched letters to shareholders with unregistered email addresses, providing a web link to access the Notice of the upcoming Extra Ordinary General Meeting.
Hexagon Nutrition Limited has issued a notice for an Extraordinary General Meeting scheduled for October 28, 2026, to seek shareholder approval for director appointments and remuneration.
Hexagon Nutrition successfully completed commercial-scale process validation for its PFH-VAP (Vitamin A Palmitate) formulation. The company will now proceed with steps for commercializing the product under "VIT A+".
Hexagon Nutrition Ltd has scheduled a Board Meeting for September 30, 2026, to discuss requisition letters for appointing directors and approving remuneration.
Hexagon Nutrition Limited announced the appointment of an Executive Director, re-appointment of a Joint Managing Director, and the appointment of a Secretarial Auditor.
Hexagon Nutrition informed exchanges that its promoters abstained from voting on certain resolutions. The company is currently seeking independent legal advice regarding this matter.
Promoters and promoter group members of Hexagon Nutrition Ltd purchased 40,000 equity shares via open market transactions, with a total consideration of ₹0.26 Crore.